VRPX Biotechnology Penny Stock Post EarningsVRPX was on a downtrend from mid-February into a reversal the beginning of May. VRPX
beat earnings up still has no cash flow which is very common in this subsector. VRPX is priced
on the potential of future earnings. The short and long-moving averages ratio shows bullish
momentum also shows strength with an upper Bollinger Band "walk". Price has climbed over
the POC line so it is higher than the mean of the share price traded for the duration of the
volume profile. I see this as a risky long setup expectant of a 40% profit based on the target
of the YTD high in February.
Earningsplay
BLUE Biotechnology New Earnings Catalyst LONGBlueBird Bio / BLUE had an earnigns report this past week showing earnings for the firat time
but revenue was far below analyst's projections. Price has appreciated 40% in the 4 weeks
since earnings which is about 500% annualized. GO BLUE.
On the daily chart, price was above VWAP and consolidating much of last fall then dropped
this YTD until the earnings report of last week. An uptrend is seen after the earnings.
This has been a significant reversal sustained over the past month
with price rising above the support / demand zone below it. At present, price is one
standard deviation below VWAP making it undervalued and ascending.
I see this as a risky long trade like many biotechology penny stocks but with a decent
probability of profit in consideration of a target of 6.15 which is the top of the long
term high volume area. the stop loss is just below the POC line of the volume profile
at 3.15 An entry at 4.62 ( limit order above SMA200 (redlne) would yield at profit of
1.50 with a risk of 0.48 making for a R:R of 3:1. Another earnings report is coming up this
week. If it is favorable, BLUE could go parabolic to hit the target in a day or two.
If not, it will be time to exit the trade.
Long Trade in HIMSHIMS has been a market-leading stock for several months. It has tripled since October and is now consolidating at all-time highs before its earnings announcement.
The company is scheduled to report after market close on Monday, 5/9.
If I were a gambler, my bet would be that they beat and surge higher. Personally, I’m not willing to risk it which is why I recently covered my position in HIMS for a quick profit.
But if Monday’s numbers are good, I will consider buying back in on Tuesday morning.
MRNA ? Buy Weakness MRNA descended this past winter off a head-and-shoulders pattern on the daily chart just under
the demand zone as shown by the LuxAlgo indicator. Price is now in a downtrend heading into
earnings tomorrow. MRNA needs to show something good otherwise it will break through the
demand zone and keep going down.
This is a risky earnings play betting that something will show up on the report to buoy up the
company and its stock. I will risk 0.01% of the trading account on a call option with DTE 5/19/23
looking for a minor surge and so a good quick profit.
( see also the link below)
Syngene - Breakout after a long timeAfter facing resistance at 640-660 zone, NSE:SYNGENE has finally given breakout.
The Company is also an Easy Earnings Comparison candidate with better visibility of June quarter results.
Easy Earnings Comparison is a case where the probability of reporting bumper results in the next upcoming quarter is high. The concept of EEC is explained in the book ‘Insider Buy Superstocks’ by Jesse Stine.
Z Zillow Group Options Ahead of EarningsIn my opinion, Zillow, a well-known online real estate platform, is poised to witness a significant drop in revenue this quarter due to various factors.
Firstly, there seems to be a lack of interest among potential customers in utilizing their services.
Additionally, with interest rates currently high, it is possible that fewer people will be interested in purchasing homes, which could further impact Zillow's revenue.
These challenges, along with other market factors, make it a tough quarter for Zillow, and the company will need to navigate these challenges carefully to maintain their market position.
Now analyzing the options chain of Z Zillow Group prior to the earnings report this week,
I would consider purchasing the 40usd strike price Puts with
an expiration date of 2023-12-15,
for a premium of approximately $4.35.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
I am interested to hear your thoughts on this strategy.
ABT Abbott Labs Med Tech Short Setting UpABT is shown on a 4H chart as setting up for a short trade.
Demand and Summply Zones are charted by the LuxAlgo indicator.
Price touched the supply zone five times in December- January then
descended and touched the demand zone several times in
mid-March.
Fundamentally, earnings reports have been solid. Medical stocks
are generally independent of the economy and recession resilient.
ABT has risen off the base of bottoms at support . Relative volume
exceeds that of the past year showing investor/trader interest
has increased. I think it will progress to
touch the supply / resistance zone another once or twice
and then reverse into a solid downtrend. I see this as worth watching
this upcoming week for the reversal.
Intapp INTA Cloud Software Services Tech LONG As can be seen on the 2H Chart INTA is on pacing over a 350% annualized gain
without any major pivots. The volume indicator shows a dramatic increase
in volume realtive to the year prior. INTA is capturing alpha consistently
in a hypergrowth mode as can be seen by reviewing the earnings beats quarter
after quarter. This is clear and obvious entry with earnings coming on
May 8th. I originally bought options last summer after the double bottom
and have added a couple of weeks before each earnings .
Price recently bounced down 10% from minor resistance representing
a small pullback with space above in the runup for the earnings report.
I see a potential return of 15% in 10 trading days or less and
75-100% for call options with expiration of 5/19/23 in consideration
of the pullback described above and shown on the chart
FRC Reminder | Weekly Outlook NASDAQ and SPX at KEY Resistance |- Both SPX and NASDAQ close right under resistance
- NYSE:FRC potentially get take over by government that means it would likely get delisted meaning goes to 0
- currently neutral daily trend for SPY & QQQ need to see consolidation soon. retracement size will be key here
VZ Verizon Communications Options Ahead of EarningsIf you haven sold VZ here:
Then analyzing the options chain of VZ Verizon Communications prior to the earnings report this week,
I would consider purchasing the 37usd strike price Puts with
an expiration date of 2023-5-19
for a premium of approximately $0.84
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
I am interested to hear your thoughts on this strategy.
APLT Biotech NASDAQ Penny LONGApplied Therapeutics is an uptrending biotechnology company that has earnings
in prior quarters and is heading into another earnings report about may 11th.
The run up in price cction is largely on the proposition of future growth much
like TSLA back in the day.
On the chart besides the obvious uptrend, the volume indicator shows a dramatic
volume surge compared with the running 50 day average while the MACD shows
the lines above the histogram and running upward and parallel.
The ideal entry would be a pullback as the price is now quite extended however
I do not believe that will occur until at least after earnings. I believe
this strong runner will continue until earnings unabated.
As a penny stock many shares can be taken and then the position can be closed
in partials along the way thus taking profits and decreasing the risk in steps.
The same applies to the call options.
Dancing on the Ceiling In recent days, a variety of technology stocks have surged as a result of robust earnings reports. Microsoft's impressive cloud and AI performance have been particularly noteworthy, leading to a ~8% increase in its stock value. The company was on the verge of breaking its single-day record for market capitalization growth.
In contrast, cryptocurrency markets have experienced a far more substantial upswing than equities over the past few days. Bitcoin has once again spearheaded the crypto rally, as expectations for future rate hikes dropped substantially due to continuing cracks in the regional banking system. However, this time, the change in the narrative was triggered by a larger-than-anticipated decline in deposits for First Republic (FRC), which has inflicted severe damage on FRC’s balance sheet and will be difficult to overcome. On Tuesday, FRC's stock plunged by about 49%, followed by another 25% drop on Wednesday morning.
In other news, the ongoing U.S. debt ceiling crisis presents a compelling and potentially precarious situation that warrants close attention. Earlier in January, the U.S. government reached its borrowing limit and has since relied on "extraordinary measures" to manage its cash flow due to the absence of new treasury issuances. As a result, the Treasury's cash balance has been steadily decreasing this year, and financial markets are becoming increasingly concerned as funds are expected to run out by June, potentially leading the government to default on its debt obligations. This scenario merits close monitoring, as evidence suggests that a technical default could trigger contagion effects, which, in a worst-case scenario, could potentially double the U.S. unemployment rate to around 7%. Furthermore, a divided Congress will make raising the debt ceiling particularly challenging for Democrats unless compromises are reached. Market apprehensions are evident in soaring credit default swap spreads—an indicator of the cost to protect against a U.S. government default—as well as the spread between 1-month and 3-month Treasury Bill yields (approximately 3.4% vs around 5.1%) widening. Recently investors have sought 1-month Treasury Bills that mature before the predicted exhaustion of government funds, causing the price of 1-month Bills to rise and their yield to fall.
From a technical standpoint, Bitcoin has experienced a minor pullback from its local top of around HKEX:31 ,000 and has since tested the 50-day moving average before regaining some bullish momentum. In the event of another pullback, traders will likely watch for the 50-day moving average to serve as support once again. MA9 and MA50 are also beginning to converge, with a potential crossing of MA9 below MA50 imminent. This would be a bearish signal. When MA9 previously crossed above MA50, Bitcoin gained significant momentum, underscoring the importance of a potential crossing of MA9 below MA50.
Looking ahead, key dates to monitor include May 3rd and 4th, when the upcoming FOMC meeting is scheduled. The Federal Reserve has already hinted at a further 25 basis point hike, which the market has likely priced in. Nonetheless, exercising caution is advisable, as the Fed may take unexpected actions during this meeting.
Will this FVG get filled anytime soon?NASDAQ:META
Earnings out
Either you got rekt, or you hit the jackpot
$Tesla Post Earnings levels to watchNow that we have a defined structure i think the picture has cleared up some for some trade opportunities.
ACHV a Biotech company after earningsACHV on the 4H seems to be demonstrating a "High Bull Flag Pattern"
after a big uptrend to start the year. Earnings on Thursday 3/16 were
quite favorable.On the relative volume indicator Friday, May 17th
showed a paradoxical huge selling volume spike to finish out this week.
( I mislabelled this as upcoming on the chart)
Paradoxically, the last earnings report in November was poor but
resulted in strong upward price action.
The MACD histogram is at the zero line.
Will ACHV resume the uptrend after earnings? Was the selling volume
an institutional trader fake out to set up a lower price to buy call options?
According to Tip Ranks, the analysts give ACHV a high rating with significant
upside. See the link below Who knows but this may be worth watching for signs of
buying volume and accumulation to fuel bullish momentum.
UAL United Airlines Holdings Options Ahead of EarningsIf you haven`t bought UAL here:
Then analyzing the options chain of UAL United Airlines Holdings prior to the earnings report this week, I would consider purchasing
Calls with a 45usd strike price and an expiration date of 2023-6-16, for a premium of approximately $1.65.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
I am interested to hear your thoughts on this strategy.
$BAC Technical Analysis: Key Levels to Watch Ahead of EarningsIn this video, we'll take a closer look at the technical analysis of Bank of America ( NYSE:BAC ) ahead of earnings and identify key levels to watch. Starting with the weekly chart, we'll analyze the overall trend and momentum of the stock. Moving to the daily chart, we'll look at recent price action and important levels of support and resistance. Next, we'll examine the 4-hour chart for any short-term trends or patterns. Finally, we'll analyze the 1-hour chart to identify potential entry and exit points for traders. By the end of this video, you'll have a better understanding of the technical outlook for NYSE:BAC and key levels to watch ahead of earnings.
Falling Wedge Heading Into EarningsPosting a quick update here as CRWD has been holding a macro-downtrend for some time now, and is heading into earnings looking quite bullish. CRWD is holding a massive falling wedge on its daily & weekly timeframes, (See Attached Charts Below), is sitting right on its 50-day EMA with the others starting to curl upwards, Bollinger bands are squeezing (Not Pictured), along with holding a bullish ABCD Elliot Wave on the daily timeframe and some gaps way on the upside still left to be filled. Additionally, CRWD is holding the same falling wedge on the weekly timeframe, accompanied by a massive bullish harmonic pattern as well as some bullish hidden divergence on the RSI. Will be looking for a breakout from this wedge (Broader Markets Permitting) - Just some support and resistance levels along with some RSI-based supply and demand zones to keep an eye on in the meantime - Bullish and looking for a breakout from this wedge
-- Price Targets & Charts Attached Below--
PT1- $129.71
PT2- $134.26
PT3- $141.71
PT4- $147.90+
--Weekly Timeframe--
AAPL bullish hammer at the beginning of wave 3 uptrendAAPL bullish hammer at the beginning of wave 3 uptrend don't hold over earnings.
SOL rises to $21.20 is bullish TL;DR Breakdown
Solana price analysis shows a bullish trend
Resistance for SOL is present at the $21.32 mark
Support for the SOL token is present at $20.69
Solana price analysis shows a bullish trend as the token surged above the $21.00 level, and it is currently trading at $21.20. This is a 2.25% increase from the previous 24 hours and shows that the bullish pressure behind SOL continues to grow. The current resistance for SOL is present at the $21.32 mark, so if the price breaks above this level, then we can expect further gains in the near term. On the flip side, the current support for the SOL token is present at $20.69, and if it holds, then we can expect a continuation of its bullish trend.
PLSE Earnings Play Long Biotech Pulse Biosciences broke out today from a positive earnings report.
Biotechnology stocks often burn cash on a slow growth cycle.
This company is making money and so the expected reaction occurred.
The volume indicator shows selling pressure in the lead-up to today's earnings.
After the report, the reversal to buying pressure occurred nearly immediately.
The MACD lines crossed under the histogram and then quickly reached
the horizontal zero line serving as a confirmation.
I expect a good follow-through next week. This may be a great penny stock
to trade or even invest.
HYMC Mining Stock swing LONGSee the 4H chart for details. The analysts to not have great ratings but I have learned to
respect chart patterns The falling wedge here is expectant for a bullish breakout upwards.
Earnings are coming and a good report is expected with fixed costs and rising gold and silver
prices. This is the timely catalyst for a trade but not an investment. The penny stock
is selling at a 95 % discount off its price 2-3 years ago. I has nowhere to go but up.
It could be a takeover candidate of one of the larger and more financially stable mining stocks.
All in all, I think this is a good buy going into earnings. See also my idea on spot gold.
.
GORO is another ticker worth a good look right now but remember all that glitters
is not gold. Speaking of miners I have a long idea for BTBT, a crypto miners
which has upcoming as well.
Falling Wedge- Bullish - UpdateENPH has been trading sideways for quite some time now while simultaneously getting beaten down by the broader markets, and testing a very strong resistance level circa $223-214.00. However, ENPH has seemingly found a bottom with a significant amount of bullish flow coming in while heading into earnings on 4/23'. From a fundamental standpoint, relative to others in the sector such as FSLR, ENPH is undervalued compared to other big names in the sector. Nevertheless, ENPH is setting up quite nicely here, hovering in and out of oversold territory while holding a massive falling wedge, accompanied by hidden bullish divergence on the RSI on the weekly timeframe (See Attached Chart Below). Furthermore, ENPH is sitting right on its 50-day SMA while bulls & bears are pulling. Regardless, Bullish and will be looking for a breakout from this wedge (Broader Market Conditions Permitting)- Just some support and resistance levels to watch along with some RSI-based supply and demand zones to keep an eye on in the meantime --Previous Charts Attached Below As Well As Price Targets--
PT1- $222.58
PT2- $228.34
PT3- $234.62
PT4- $240.37 +
Weekly Timeframe
Fundamentals
Previously Charted
